Gonçalo Brites completed his Bsc degree in Biotechnology at Polytecnic Institute of Coimbra- Agricultural College of Coimbra, Portugal (2010 - 2013). He completed his master’s degree in Pharmaceutical Biotechnology in the Faculty of Pharmacy, University of Coimbra. In 2015 he won a research grant supported by Liga Portuguesa Contra o Cancro 2015 (LPCC/ANA). Since 2018, he is doing his PhD in Pharmaceutical Sciences in the Drugs R&D Program in Toxfinder Lda, and in the Faculty of Pharmacy in the University of Coimbra and Center for Neuroscience and Cell Biology, Portugal.
Sara Almeida obtained a graduation and master’s degree in Medicinal Chemistry at Faculty of Sciences and Technology at the University of Coimbra (FCTUC) in July 2017. In April 2018, obtained a PhD fellow in Drugs R&D PhD program at Faculty of Pharmacy at the University of Coimbra (FFUC) and in ICNAS: Produção Unipessoal Lda, where she has been working at the interface between radiochemistry and in vitro studies.
Master in Pharmaceutical Sciences, Faculty of Pharmacy, University of Coimbra (2011 - 2016). From 2016 to 2018, she worked on quality control of cosmetics, medical devices, and other products, at a consulting company specialized in regulatory and laboratory services for the cosmetic industry. In 2018 she obtained a doctoral fellowship under the PhD program 'Drugs R&D', from the Faculty of Pharmacy of the University of Coimbra, together with Laboratories Basi - Pharmaceutical Industry S.A.
Master in Pharmaceutical Sciences from the University of Coimbra. He began his research career at CNC in 2016 under the guidance of Professor João Laranjinha. In 2017 he entered the PhD in Pharmaceutical Sciences - specialty of Biochemistry - from the Faculty of Pharmacy of the University of Coimbra. Her doctoral project focuses on the study of signaling pathways mediated by radical species between neurons and blood vessels and their possible modulation through diet, in order to prevent the development of pathologies such as Alzheimer's disease.
Daniela Mariana Zagalo
Master in Pharmaceutical Sciences, Faculty of Pharmacy, University of Coimbra. Throughout her academic career, she tried to acquire and foster knowledge in the different areas of the pharmaceutical field, through various national and international experiences, with the aim of becoming a multidisciplinary health professional.
Professional Experience: Wholesale Distribution (Plural), Clinical Analysis (FFUC), Community Pharmacy (Student Exchange Program - Budapest), Hospital Pharmacy (Erasmus - Valencia), R&D (FFUC Pharmaceutical Technology; Erasmus Postgraduate - Madrid) and Entrepreneurship and Challenge Business (FEUC). She is currently attending the Doctoral Program at Bluepharma - Pharmaceutical Industry, S.A, known as "Research and Development of Drugs" of the Foundation for Science and Technology, IP (FCT).
Master in Pharmaceutical Sciences from the Faculty of Pharmacy, University of Coimbra, in 2015. Worked in the regulatory area of medicines and cosmetics. In 2017, she took the postgraduate refresher course in Advanced Cosmetology, Faculty of Pharmacy, University of Lisbon. She is currently developing a PhD project at Bluepharma, as part of the Drugs R&D PhD program at the Faculty of Pharmacy, University of Coimbra. The project focuses on industrial research, specifically Quality by Design strategies in Industry 4.0.
BSc and MSc in Biomedical Sciences (Department of Biomedical Sciences and Medicine) - University of Algarve. Awarded with the EIT Health Doctoral Transition Innovation Fellowship 2017. Currently at the final stage of the PhD in Pharmaceutical Sciences (FFUC) in the gene therapy and innovative therapeutics field (CNC).
David Rufino-Ramos attended the Integrated Master's Degree in Pharmaceutical Sciences at the Faculty of Pharmacy of the University of Coimbra from 2011 to 2016. During this period, he joined faculty-related associativism and entrepreneurship projects and had the opportunity to perform Medical Information and Patient Safety trainee roles at Astrazeneca. After finishing the course, she received an FCT PhD scholarship to develop a project that aims to use new ways of delivering silencing sequences to the brain. The researcher has a publication and more than 10 communications at national and international congresses and has been awarded by ptRNA Society and by Boehringer-Ingelheim Fonds.
Master in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Coimbra since 2015. Upon conclusion of the master's degree, he worked in Community Pharmacy. He is currently a PhD fellow at the UC Faculty of Pharmacy in the area of Microbiology, with particular interest in the development and dissemination of polymyxin resistance mechanisms and genes in Gram negative bacteria.
A. Neves has received her Industrial Chemistry degree in 2009 and her M.Sc. in Chemistry in 2011 from University of Coimbra. During 7 years she was a research fellow in chemistry department and ICNAS-P of the same University. She has published 12 papers in international scientific journals and some oral and poster communications. Since March 2015 is head of quality control at ICNAS-P and PhD student at same company since 2017.
M. Miranda obtained her MSc in Pharmaceutical Sciences at the University of Lisbon.
She is currently developing her PhD in partnership with Laboratórios Basi, through the Drugs R&D doctoral program. Her work focusses the development of surrogate methods able to establish the therapeutic equivalence of topically applied drugs.
João Calmeiro works in the fields of health and biomedicine. He has more than 7 years of experience in both Academia and Pharma & Biotech Industry.
BSc in Biotechnology, MSc in Pharmaceutical Biotechnology, advanced course in Biodesign at the University of Oxford and currently doing his PhD in Pharmaceutical Sciences with a specialization in Pharmacology and Pharmacotherapy.
Awarded by the Calouste Gulbenkian Foundation, Novartis, ImmunoTools and European Union (EIT Health). Member of the American Society of Clinical Oncology (ASCO).
Worked at NOVA Medical School, SICGEN (Biotech Company) and Center for Neuroscience and Cell Biology (CNC UC).
Working with the Tecnimede Group (Pharmaceutical Company) in his PhD project, aiming at the development and validation of the first pilot laboratory for cell therapy in Portugal and on novel therapies for cancer (immunotherapy).
Currently, João is working at Institut Curie, in Paris.
Completed the Integrated Master in Pharmaceutical Sciences in 2017, Faculty of Pharmacy, University of Coimbra. In 2018, he obtained a doctoral grant from the doctoral program “Research and development of drugs”, in collaboration between the Faculty of Pharmacy of the University of Coimbra and the Laboratories Basi - Pharmaceutical Industry, with the theme of developing analytical process technologies applied to injectable products.